| Jul 19 |
Silo Pharma stock plummets on $2.1M registered direct offering priced ATM
|
| Jul 19 |
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
| Jul 18 |
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
|
| Jul 18 |
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
|
| Jul 17 |
Silo Pharma files to sell 1.04M shares of common stock for holders
|
| Jul 16 |
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
|
| Jul 8 |
Silo Pharma announces global license for its PTSD and anxiety disorder treatment drug
|
| Jul 8 |
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
|
| Jun 26 |
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
|
| Jun 7 |
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
|
